Loomis, Sayles & Company’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-534
Closed -$26K 911
2017
Q4
$26K Sell
534
-83
-13% -$4.19K ﹤0.01% 739
2017
Q3
$31K Sell
617
-183
-23% -$8.77K ﹤0.01% 689
2017
Q2
$34K Sell
800
-65
-8% -$2.7K ﹤0.01% 657
2017
Q1
$35K Buy
865
+75
+9% +$2.76K ﹤0.01% 670
2016
Q4
$27K Buy
+790
New +$27.2K ﹤0.01% 732

Other funds holding OMCL

Loomis, Sayles & Company's OMCL Position: Q1 2018 in Review

Loomis, Sayles & Company sold out of Omnicell (OMCL) in Q1 2018, closing a stake of 534 shares — an estimated $26K sold.

Loomis, Sayles & Company first reported a position in OMCL in Q4 2016 and held it in 5 quarters. The position peaked at $35K in Q1 2017. 231 funds tracked by Wall St. Rank hold OMCL as of Q1 2018.

  • Loomis, Sayles & Company reported no remaining Omnicell position as of Q1 2018 after selling out during the quarter.
  • Loomis, Sayles & Company sold 534 Omnicell shares in Q1 2018, an estimated $26K.
  • Loomis, Sayles & Company first reported a position in Omnicell in Q4 2016 and held it in 5 quarters.
  • Loomis, Sayles & Company's Omnicell position peaked at $35K in Q1 2017.
  • 231 funds tracked by Wall St. Rank held Omnicell as of Q1 2018.

Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.